EichorEICHOR
Study identifier: NCT06083012 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

Condition: Atrial Fibrillation · Atrial Arrhythmia · Arrhythmias, Cardiac  ·  Sponsor: Volta Medical

PhaseN/A
Planned participants186
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this Observational Prospective Multi-center Study is to observe the acute and long-term safety and performance outcomes after spatiotemporal dispersion-based AF/AT ablation utilizing the Volta Medical AI software in "real-life" clinical practice, without any imposed clinical workflow. Moreover, this study will allow to collect medico-economic data related to the tailored ablation strategy guided by the Volta Medical AI software.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (7)

Hôpital Saint-JosephMarseille, France
Hôpital Privé Jacques CartierMassy, France
Polyclinique Saint GeorgeNice, France
Centre Cardiologique du NordSaint-Denis, France
Clinique RhénaStrasbourg, France
Clinique PasteurToulouse, France
German Heart Center MunichMünchen, Germany

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →